Pfizer and Sun settle Bosulif dispute
06-11-2019
Pfizer expects $1.9bn loss due to patent expirations
31-07-2018
08-04-2019
manuelesteban / Shutterstock.com
India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica (pregabalin).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sun Pharma, Pfizer, Lyrica, patent infringement, FDA, pregabalin, pain management